Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.


Krämer A., Bochtler T., Pauli C., Shiu K., Cook N., Janoski de Menezes J., ...More

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026 (SCI-Expanded, Scopus)